| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2875076 | The Annals of Thoracic Surgery | 2013 | 7 Pages |
Abstract
Our meta-analysis of data of approximately 5,000 patients from 17 studies showed that TAVI is likely ineffective in reducing early and midterm all-cause mortality vs AVR in high-risk patients with AS.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Hisato MD, PhD, Masao MD, Yusuke MD, Shin-nosuke MD, Takuya MD, PhD, All-Literature Investigation of Cardiovascular Evidence (ALICE) Group All-Literature Investigation of Cardiovascular Evidence (ALICE) Group,